# The Optimal Sequential Therapy After Long Term Denosumab Treatment

> **NCT05091099** · PHASE4 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 44 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** zoledronate
- **DRUG:** Alendronate and Zoledronate

## Key facts

- **NCT ID:** NCT05091099
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-10
- **Primary completion:** 2025-11-14
- **Final completion:** 2025-11-14
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05091099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05091099, "The Optimal Sequential Therapy After Long Term Denosumab Treatment". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT05091099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*